ACOG Publications

    loading  Checking for direct PDF access through Ovid


PUBLICATIONS | January 2018
WITHDRAWN The following College document has been withdrawn:
ACOG Technology Assessment No. 10: Single-Incision Laparoscopy (Obstet Gynecol 2013;122:429– 31)
REVISED The following College documents have been revised:
ACOG Committee Opinion No. 493: Cultural Sensitivity and Awareness in the Delivery of Health Care (Obstet Gynecol 2011;117:1258– 61) has been withdrawn and replaced by Committee Opinion No. 729: Importance of Social Determinants of Health and Cultural Awareness in the Delivery of Reproductive Health Care (Obstet Gynecol 2018;131:e43–8)
ACOG Committee Opinion No. 562: Müllerian Agenesis: Diagnosis, Management, and Treatment (Obstet Gynecol 2013;121:1134– 7) has been withdrawn and replaced by Committee Opinion No. 728: Müllerian Agenesis: Diagnosis, Management, and Treatment (Obstet Gynecol 2018;131:e35–42)
ACOG Practice Bulletin No. 153: Nausea and Vomiting of Pregnancy (Obstet Gynecol 2015;126:e12– 24) has been withdrawn and replaced by Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (Obstet Gynecol 2018;130:e15–30)
ACOG Practice Bulletin No. 172: Premature Rupture of Membranes (Obstet Gynecol 2016;128:165– 77) (Interim Update) has been withdrawn and replaced by Practice Bulletin No. 188: Prelabor Rupture of Membranes (Obstet Gynecol 2018;131:e1–14) (Interim Update)
REAFFIRMED The following College documents have been reaffirmed:
ACOG Committee Opinion No. 375: Brand Versus Generic Oral Contraceptives (Obstet Gynecol 2007;110:447–8)
ACOG Committee Opinion No. 434: Induced Abortion and Breast Cancer Risk (Obstet Gynecol 2009;113:1417–8)
ACOG Committee Opinion No. 484: Performance Enhancing Anabolic Steroid Abuse in Women (Obstet Gynecol 2011;117:1016–8)
ACOG Committee Opinion No. 571: Solutions for Surgical Preparation of the Vagina (Obstet Gynecol 2013;122:718–20)
ACOG Committee Opinion No. 580: Von Willebrand Disease in Women (Obstet Gynecol 2013;122:1368–73)
ACOG Committee Opinion No. 582: Addressing Health Risks of Noncoital Sexual Activity (Obstet Gynecol 2013;122:1378–83)
ACOG Committee Opinion No. 642: Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy (Joint with the Long-Acting Reversible Contraception Working Group) (Obstet Gynecol 2015;126:e44–8)
ACOG Committee Opinion No. 645: Dual Therapy for Gonococcal Infections (Obstet Gynecol 2015;126:e95–9)
ACOG Practice Bulletin No. 78: Hemoglobinopathies in Pregnancy (Obstet Gynecol 2007;109:229–37)
ACOG Practice Bulletin No. 81: Endometrial Ablation (Obstet Gynecol 2007;109:1233–48)
ACOG Practice Bulletin No. 82: Management of Herpes in Pregnancy (Obstet Gynecol 2007;109:1489–98)
ACOG Practice Bulletin No. 84: Prevention of Deep Vein Thrombosis and Pulmonary Embolism (Obstet Gynecol 2007;110: 429–40) (Correction)
ACOG Practice Bulletin No. 92: Use of Psychiatric Medications During Pregnancy and Lactation (Obstet Gynecol 2008;111:1001–20)
ACOG Practice Bulletin No. 114: Management of Endometriosis (Obstet Gynecol 2010;116:223–36)
ACOG Practice Bulletin No. 134: Fetal Growth Restriction (Joint with the Society for Maternal–Fetal Medicine) (Obstet Gynecol 2013;121:1122–33)
ACOG Practice Bulletin No. 136: Management of Abnormal Uterine Bleeding Associated With Ovulatory Dysfunction (Obstet Gynecol 2013;122:176–85)
ACOG Practice Bulletin No. 152: Emergency Contraception (Obstet Gynecol 2015;126:e1–11)
ACOG Practice Bulletin No. 154: Operative Vaginal Delivery (Obstet Gynecol 2015;126:e56–65)
ACOG Practice Bulletin No. 155: Urinary Incontinence in Women (Joint with the American Urogynecologic Society) (Obstet Gynecol 2015;126:e66–81)
ACOG Practice Bulletin No. 156: Obesity in Pregnancy (Obstet Gynecol 2015;126:112–26) (Correction)
ACOG Practice Bulletin No. 161: External Cephalic Version (Obstet Gynecol 2016;127:e54–61)
ACOG Practice Bulletin No. 168: Cervical Cancer Screening and Prevention (Obstet Gynecol 2016;128:e111–30) (Interim Update)
For more information on ACOG endorsed documents, please visit
The following publication has been endorsed by the American College of Obstetricians and Gynecologists and should be construed as ACOG clinical guidance. ACOG’s endorsement is valid for 5 years unless the document is revised or withdrawn sooner.
Testing and interpreting measures of ovarian reserve: a committee opinion. Practice Committee of the American Society for Reproductive Medicine. Fertil Steril 2015103:e9–17. Available at: Retrieved October 26, 2017.
Note: This corrects and replaces the 2012 citation for the endorsed document printed on the Breaker Page in the September 2017 issue of Obstetrics & Gynecology.
Obstetrician–gynecologists and other obstetric care providers are encouraged to visit the following resources for detailed guidance and information regarding Zika, including breaking developments.
ACOG Zika Virus Web Page: www.acog.
    loading  Loading Related Articles